Zymo Research News

Debut of Zymo Research's Epigenetic Tools and Resources

Wed, 18 Jan 2012 18:01:36 +0000

We are proud to introduce Zymo Research Corporation’s brand-new Epigenetic Tools, a free online resource for epigenetics researchers. Try Bisulfite Primer Seeker for the design of robust, unbiased post-bisulfite PCR primers from your target sequence. Users can also calculate methylation percentage by using qMethyl Calculator in conjunction with our OneStep qMethyl™ kit. As we continue to develop more tools, we will add them to the website in order to continue to simplify your epigenetics research and share our wealth of knowledge and experience in this area.

Zymo Research and BaseClear Bring State-of-the-Art EpiQuest™ Methylome Sequencing Technology to Europe

Wed, 19 Oct 2011 13:46:59 +0000

Zymo Research, a specialist in the field of epigenetics for nearly a decade, has entered into a new collaboration with BaseClear to offer a unique Epigenetic Biomarker Discovery Service in Europe.

Orange, California, USA and Leiden, The Netherlands, Oct. 19th , 2011 — In collaboration with Zymo Research, BaseClear is now able to offer methylome analysis, which yields the DNA methylation profile of an entire genome (at a genomic scale). BaseClear customers will already be familiar with Zymo Research through the laboratory products (reagents) that constitute part of BaseClear’s lab product portfolio. Last year, Zymo Research developed a new method which combines next generation sequencing and bioinformatics with their well-established bisulfite technologies for comprehensive DNA methylation analysis (EpiQuest™). With the EpiQuest™ service Zymo Research and BaseClear are the first to offer a complete and extensive DNA methylation service based on next generation technology to the market. European researchers can now make use of this service via BaseClear. Customers can opt for a basic variant that provides next generation sequencing data aligned with a reference genome (through three UCSC genome browser tracks), and a full service variant, which includes comprehensive bioinformatics analysis. Advantages of this new service include: precise quantitation, single nucleotide resolution, low DNA input, applicable to a broad range of sample sources, consolidated data delivery, and more. Customized services can, of course, always be provided upon request. Determining DNA methylation patterns on a genomic scale and discovering new epigenetic biomarkers are now feasible. Dr. L. Jia, Zymo Research says: “The services should have a profound impact on candidate biomarker discovery and how we diagnose disease. Further, these technologies should make available the creation of companion diagnostics that coincide with therapeutic development. We are excited with this collaboration with which we hope to expand the epigenetics portfolio enabling us to better serve customers in Europe" Drs. B. Reichert, BaseClear adds: “The extension of our services with the EpiQuest service fits perfectly in our strategy to build a complete package of high quality genome analysis service. We are also excited about strengthening of our collaboration with Zymo Research and expect that joining forces in this fast developing field of research will allow us to add more services that would benefit to our customers in the near future.”

About ZYMO RESEARCH CORPORATION Zymo Research, a private company based in Orange, California, and founded in 1994, has been proudly serving the scientific community by providing proven, trusted, and state-of-the-art DNA and RNA research technologies at affordable prices. The company’s philosophy is to provide the highest quality products in the industry while ensuring they are both simple to use and robust in their performance. Although historically recognized for its innovative DNA and RNA purification technologies, Zymo Research has recently received much attention for its rapidly expanding epigenetics portfolio of products. Branding itself “The Epigenetics Company”, it is Zymo Research’s objective to develop and provide the most comprehensive set of research tools for DNA methylation analysis and epigenetics research available today.

About BASECLEAR BaseClear B.V., a private company based in Leiden, The Netherlands, was founded in 1993 as a service laboratory dedicated to deliver high quality DNA based services to researchers in the life sciences. At date the company offers a broad range of services ranging from single read DNA sequencing, Whole genome sequencing using NextGeneration platforms, synthetic DNA biology and services for forensics and quality control purposes and a whole package of supporting technologies. BaseClear strives to deliver services at an exceptional high quality level and with a strong focus on customer satisfaction, which is guaranteed through our ISO 17025 quality system and further through Illumina CSpro and Nimblegen CSpro certifications. ‘BaseClear, for 100% DNA results.’ For more information, contact: services@zymoresearch.com www.zymoresearch.com

Simplify High-Throughput Biomarker Screening with Bisulfite-Free OneStep qMethyl™ Kit

Tue, 19 Apr 2011 16:53:07 +0000

Zymo Research's OneStep qMethyl™ technology offers an enticing alternative to long and tedious bisulfite sequencing. Through an optimized workflow that literally involves one step, researchers are able to use restriction enzyme digestion and qPCR to determine methylation percentage of many samples or multiple loci in just 4 hours. The advantages and applications of the OneStep qMethyl kit were recently featured in this week's EpiGenie.

EpiQuest Debut... Highlighted by EpiGenie

Wed, 16 Feb 2011 14:44:23 +0000

"The Beauty of Science is to Make Things Simple" is the mantra by which Zymo Research operates. This goal has never been truer than with the introduction of Zymo's new EpiQuest service for genome-wide DNA methylation analysis. In their most recent article on DNA methylation, EpiGenie discusses this most consolidated service platform. The article features a concise overview of the technology and its affordability to provide researchers with publication quality data as a rapid means for epigenetic sample comparison, biomarker discovery, etc. The article also offers an insightful interview with one of our scientists, highlighting the advantages of the new EpiQuest service. (http://www.epigenie.com/Methods/Zymo-DNA-Methylation-Sequencing.html)

EpiQuest - a Genome-wide DNA Methylation Analysis Service is Launched

Wed, 09 Feb 2011 01:10:38 +0000

Zymo Research Corp. announced the first in a line of services to simplify and streamline epigenetic research. Starting today Zymo Research takes epigenetics research to the next level with the EpiQuest™ Genome-Wide DNA Methylation Analysis Platform. This new service combines Next-Gen sequencing with well-established bisulfite technologies for the most comprehensive DNA methylation analysis service available. Streamlined sample prep, cutting-edge bioinformatics, and consolidated data delivery take the difficulty out of methylation characterization and simplify epigenetic biomarker discovery. With this new service all you need to do is ask the question, we take care of the rest. Traditionally recognized for its innovative DNA and RNA purification technologies, Zymo Research has pioneered a niche for itself in the now rapidly growing field of epigenetic research. For nearly a decade Zymo Research has provided scientists with high quality state of the art products for epigenetics. Our bisulfite treatment technologies and DNA methylation standards are the most popular and cited to date for DNA methylation detection. We will continue as The Epigenetics Company to expand our DNA methylation and hydroxymethylation portfolio of products and services for years to come.

Frost & Sullivan Awards Zymo Research Its 2010 Best Practices Award

Tue, 05 Jan 2010 11:53:07 +0000

Orange, California, January 5, 2010 – Zymo Research Corp. announced today that the company has received the 2010 Frost & Sullivan Best Practices Award for Leadership in Epigenetics Product Quality.

“Frost & Sullivan proudly recognizes Zymo Research as the recipient of the 2010 North American Product Quality Leadership Award for Epigenetics. Zymo Research, a private company based in Orange, California, provides top quality products for nucleic acid purification and analysis, and the burgeoning field of epigenetics. Within these focuses, Zymo Research successfully competes with the largest of life sciences companies by constantly innovating and never compromising on quality. The company has fostered a stellar reputation amongst the research community for delivering the highest quality products that are easy to use and perform reliably. For its commitment to product quality and enabling more effective and precise research, Zymo Research is the ideal recipient of the Frost & Sullivan Product Quality Leadership Award.”

“All Product Quality Leaders share a strategy of continually updating products based on market and customer needs. While Zymo’s original EZ DNA Methylation™ kit remains one of the best-selling products on the market, the company has developed multiple updates to the original to improve features and cater to customer demands. Zymo launched the EZ DNA Methylation-Gold™ Kit to improve on processing speed, decreasing reaction time to less than three hours by consolidating steps. The EZ DNA Methylation-Direct™ Kit allows customers to perform conversion directly from cells, tissue, or blood, rather than requiring purified DNA as the input material. The EZ DNA Methylation-Startup™ Kit caters to the first-time user, providing an easy-to-use complete system for bisulfite treatment with controls and PCR amplification. Uniquely, Zymo offers the original, Gold™, and Direct™ kits in high-throughput (96-well) shallow-well or deep-well formats as many laboratories lack the instrumentation to handle deep-well formats. While other vendors only offer single column format conversion kits, by supplying a range of kits with various features, Zymo satisfies the specific needs and applications of various types of DNA methylation end-users. This obsession with product improvement has allowed Zymo to undoubtedly remain atop the market in both quality perception and market share.” Frost & Sullivan, http://www.frost.com.

About Zymo Research
Zymo Research, a private company based in Orange, California, and founded in 1994, has been proudly serving the scientific community by providing proven, trusted, and state-of-the-art DNA and RNA research technologies at affordable prices. The company’s philosophy is to provide the highest quality products in the industry while ensuring they are both simple to use and robust in their performance. Although historically recognized for its innovative DNA and RNA purification technologies, Zymo Research has recently received much attention for its rapidly expanding epigenetics portfolio of products. Branding itself “The Epigenetics Company”, it is Zymo Research’s objective to develop and provide the most comprehensive set of research tools for DNA methylation analysis and epigenetics research available today.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.